These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 20854899)

  • 1. Tick-borne encephalitis after vaccination: vaccine failure or misdiagnosis.
    Grgič-Vitek M; Avšič-Županc T; Klavs I
    Vaccine; 2010 Oct; 28(46):7396-400. PubMed ID: 20854899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High burden of tick-borne encephalitis in Slovenia--challenge for vaccination policy.
    Grgič-Vitek M; Klavs I
    Vaccine; 2011 Jul; 29(32):5178-83. PubMed ID: 21620916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reliable surveillance of tick-borne encephalitis in European countries is necessary to improve the quality of vaccine recommendations.
    Stefanoff P; Polkowska A; Giambi C; Levy-Bruhl D; O'Flanagan D; Dematte L; Lopalco PL; Mereckiene J; Johansen K; D'Ancona F;
    Vaccine; 2011 Feb; 29(6):1283-8. PubMed ID: 21145914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunity against tick borne encephalitis virus (TBE) in population of forest workers in Bialowieza].
    Siennicka J; Trzcińska A; Gut W
    Przegl Epidemiol; 2010; 64(2):303-5. PubMed ID: 20731242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in vaccination against tick-borne encephalitis.
    Rendi-Wagner P
    Expert Rev Vaccines; 2008 Jul; 7(5):589-96. PubMed ID: 18564014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Field effectiveness of vaccination against tick-borne encephalitis.
    Heinz FX; Holzmann H; Essl A; Kundi M
    Vaccine; 2007 Oct; 25(43):7559-67. PubMed ID: 17869389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serological response to tick-borne encephalitis (TBE) vaccination in the elderly--results from an observational study.
    Jílková E; Vejvalková P; Stiborová I; Skorkovský J; Král V
    Expert Opin Biol Ther; 2009 Jul; 9(7):797-803. PubMed ID: 19527104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term persistence of tick-borne encephalitis antibodies in children 5 years after first booster vaccination with Encepur Children.
    Wittermann C; Petri E; Zent O
    Vaccine; 2009 Mar; 27(10):1585-8. PubMed ID: 19162115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A campaign to increase the vaccination rate in a highly endemic tick-borne encephalitis region of Slovenia.
    Košnik IG; Lah AK
    Vaccine; 2013 Jan; 31(5):732-4. PubMed ID: 23246549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistence of antibodies after vaccination against tick-borne encephalitis.
    Rendi-Wagner P; Zent O; Jilg W; Plentz A; Beran J; Kollaritsch H
    Int J Med Microbiol; 2006 May; 296 Suppl 40():202-7. PubMed ID: 16524776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistence of immunity to tick-borne encephalitis after vaccination and natural infection.
    Baldovin T; Mel R; Bertoncello C; Carpenè G; Soppelsa F; Giliberti A; Baldo V
    J Med Virol; 2012 Aug; 84(8):1274-8. PubMed ID: 22711356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term persistence of tick-borne encephalitis antibodies in adults 5 years after booster vaccination with Encepur Adults.
    Plentz A; Jilg W; Schwarz TF; Kuhr HB; Zent O
    Vaccine; 2009 Feb; 27(6):853-6. PubMed ID: 19071180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tick-borne encephalitis and its prevention in Hungary.
    Lontai I; Straub I
    Med Pregl; 1998; 51 Suppl 1():21-3. PubMed ID: 9769651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistence of protective immunity following vaccination against tick-borne encephalitis--longer than expected?
    Rendi-Wagner P; Kundi M; Zent O; Dvorak G; Jaehnig P; Holzmann H; Mikolasek A; Kollaritsch H
    Vaccine; 2004 Jul; 22(21-22):2743-9. PubMed ID: 15246606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of tick-borne encephalitis vaccination in Latvia, 2018-2020: an observational study.
    Zavadska D; Freimane Z; Karelis G; Ermina I; Harper LR; Bender C; Zhang P; Angulo FJ; Erber W; Bormane A; Gutmane E; Litauniece ZA; Tihonovs J; Griskevica A; Madhava H; Jodar L
    Clin Microbiol Infect; 2023 Nov; 29(11):1443-1448. PubMed ID: 37422077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [After vaccination for tick-borne encephalitis must onset of neurologic disorders be expected?].
    Hofmann H
    Wien Klin Wochenschr; 1995; 107(17):509-15. PubMed ID: 7483633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tick-borne encephalitis (TBE) trends in epidemiology and current and future management.
    Petri E; Gniel D; Zent O
    Travel Med Infect Dis; 2010 Jul; 8(4):233-45. PubMed ID: 20970726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tick-borne encephalitis (TBE) vaccination: applying the most suitable vaccination schedule.
    Schöndorf I; Beran J; Cizkova D; Lesna V; Banzhoff A; Zent O
    Vaccine; 2007 Feb; 25(8):1470-5. PubMed ID: 17196713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of tick-borne encephalitis by FSME-IMMUN vaccines: review of a clinical development programme.
    Loew-Baselli A; Poellabauer EM; Pavlova BG; Fritsch S; Firth C; Petermann R; Barrett PN; Ehrlich HJ
    Vaccine; 2011 Oct; 29(43):7307-19. PubMed ID: 21843576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of serum levels of tick-borne encephalitis (TBE) virus antibodies after administration of FSME inject vaccine].
    Pancewicz SA; Hermanowska-Szpakowicz T
    Przegl Epidemiol; 2002; 56 Suppl 1():116-21. PubMed ID: 12194225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.